Showing results (201-210 of 289) with videos related to

Sort By:
Pageof 29
Cancer Cell|August 15, 2006
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironmentAnuradha Budhu, Marshonna Forgues, Qing-Hai Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factorJian Zhou, Zhao-You Tang, Jia Fan, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 3, 2004
[Three-grade criteria of curative resection for primary liver cancer]Zeng-chen Ma, Li-wen Huang, Zhao-you Tang, et al.
International Journal of Cancer|May 6, 2011
Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinomaYing Liang, Wei-Wei Li, Bi-Wei Yang, et al.
Oncology Reports|January 24, 2017
Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathwayCheng-Dong Qin, De-Ning Ma, Zheng-Gang Ren, et al.
Annals of Translational Medicine|July 16, 2021
Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scanXiao-Long Li, Bin Xu, Xiao-Dong Zhu, et al.
Oncotarget|October 31, 2015
The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cellsYang Bu, Qing-An Jia, Zheng-Gang Ren, et al.
World Journal of Gastroenterology|June 5, 2002
P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resectionLun-Xiu Qin, Zhao-You Tang, Zeng-Chen Ma, et al.
World Journal of Gastroenterology|May 24, 2006
Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experienceJian Zhou, Jia Fan, Zheng Wang, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2006
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinomaHui Zhang, Qing-Hai Ye, Ning Ren, et al.
Pageof 29